查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1477166

生物製药和生物医学市场，按产品类型、应用、治疗领域、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Biopharmaceutical and Biomedicine Market, By Product Type, By Application, By Therapeutic Area, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 300 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2023年生物製药和生物医学市场规模为6,213.12亿美元，2024年至2032年复合年增长率为9.5%。

生物製药和生物医学市场-市场动态

生物製药和生物医学领域的产品上市和批准率激增

生物製药和生物医药行业的产品上市和批准率显着飙升，显示该行业的快速创新和扩张。美国食品药物管理局（FDA）的资料显示，近年来获得监管批准的生物製药产品数量稳定增加，每年新药核准数量创历史新高。这一趋势凸显了该行业致力于透过开发突破性的生物製药和生物医学产品来解决未满足的医疗需求并改善患者的治疗结果。

生物製药和生物医药市场-关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 9.5% 左右的复合年增长率成长

根据产品类型细分，预计单株抗体将在 2023 年呈现最大市场份额

从应用细分来看，治疗类是2023年的主导类型

按地区划分，北美是 2023 年的主要收入来源

生物製药和生物医学市场-細項分析：

全球生物製药和生物医学市场根据产品类型、应用、治疗领域和地区进行细分。

根据产品类型，市场分为两类： 单株抗体，广泛用于癌症治疗和自体免疫疾病等治疗应用。奈米医学用于在分子层面上诊断、治疗和预防疾病，提供标靶递送并增强药物递送和成像应用的功效。

根据应用市场分为三类： 用于治疗疾病和医疗状况。诊断用于识别和诊断疾病或病症。研究与开发应用于药物发现和开发的科学研究和实验研究。

生物製药和生物医药市场-地理洞察

从地理来看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太、中东和非洲等地区。这些区域根据开展业务的国家进一步划分。

北美和欧洲是主要参与者，拥有先进的医疗基础设施、强大的研发能力和有利的监管环境。同时，在医疗保健支出增加、慢性病盛行率增加以及创新疗法普及的推动下，亚太地区展现出巨大的成长潜力。拉丁美洲以及中东和非洲地区也提供了市场扩张的机会，儘管面临医疗基础设施、负担能力和监管复杂性的挑战。

生物製药和生物医药市场-竞争格局：

几个主要参与者透过研发投资、併购和策略合作伙伴关係等策略争夺主导地位。罗氏、辉瑞和强生等公司凭藉多样化的生物製药产品组合和广泛的全球影响力引领市场。此外，安进（Amgen）、百健（Biogen）和吉利德科学（Gilead Sciences）等创新生物技术公司透过突破性疗法和新型候选药物为市场竞争力做出了贡献。随着竞争的加剧，企业专注于透过产品创新、监管审批和市场扩张努力来实现差异化。

最近的发展：

2022 年 5 月，JSR Life Sciences 推出了一个名为 Similis Bio 的新业务部门，旨在与生物製药公司合作，提高与生物相似药开发相关的效率并降低成本。

目录

第一章：生物製药和生物医学市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按产品类型分類的生物製药和生物医学市场片段
    • 生物製药和生物医学市场片段（按应用）
    • 按治疗领域分類的生物製药和生物医学市场片段
    • 按国家/地区分類的生物製药和生物医学市场摘要
    • 按地区分類的生物製药和生物医学市场片段
  • 竞争洞察

第 3 章：生物製药和生物医学主要市场趋势

  • 生物製药和生物医学市场驱动因素
    • 市场驱动因素的影响分析
  • 生物製药和生物医学市场限制
    • 市场限制影响分析
  • 生物製药和生物医学市场机会
  • 生物製药及生物医药市场未来趋势

第 4 章：生物製药和生物医学产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：生物製药和生物医学市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：生物製药和生物医学市场格局

  • 2023年生物製药和生物医学市场份额分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：生物製药和生物医学市场 - 按产品类型

  • 概述
    • 按产品类型分類的细分市场占有率分析
    • 单株抗体
      • 疫苗
      • 重组人类胰岛素
      • 人类生长激素
      • 促红血球生成素
      • 干扰素
      • 其他的
    • 奈米医学
      • 细胞与基因治疗
      • 生物资讯学
      • 分子酵素和试剂盒

第 8 章：生物製药和生物医学市场 - 按应用

  • 概述
    • 按应用分類的细分市场占有率分析
    • 疗法
    • 诊断
    • 研究与开发

第 9 章：生物製药和生物医学市场 - 按治疗领域

  • 概述
    • 按治疗领域分類的细分市场占有率分析
    • 肿瘤学
    • 神经病学
    • 心臟病学
    • 免疫学
    • 传染性疾病
    • 罕见疾病

第 10 章：生物製药和生物医学市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美生物製药和生物医学主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按产品类型）
    • 北美市场规模和预测（按应用）
    • 北美市场规模与预测（按治疗领域）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲生物製药和生物医学主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按产品类型）
    • 欧洲市场规模和预测（按应用）
    • 欧洲市场规模与预测（按治疗领域）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区生物製药及生物医学主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（依产品类型）
    • 亚太地区市场规模与预测（按应用）
    • 按治疗领域分類的亚太市场规模和预测
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲生物製药和生物医学主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按产品类型）
    • 拉丁美洲市场规模与预测（按应用）
    • 拉丁美洲市场规模与预测（按治疗领域）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲生物製药和生物医学主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按产品类型）
    • 中东和非洲市场规模及预测（按应用）
    • 中东和非洲市场规模及预测（按治疗领域）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：主要供应商分析 - 生物製药和生物医学产业

  • 竞争仪表板
  • 公司简介
    • Amgen Inc.
    • F. Hoffmann-La Roche Ltd
    • Johnson & Johnson Services, Inc.
    • Pfizer Inc.
    • Sanofi
    • Eli Lilly and Company
    • AbbVie Inc.
    • Novo Nordisk A/S
    • Bristol-Myers Squibb Company
    • NanoString
    • QIAGEN
    • Affimed GmbH
    • GSK plc.
    • Merck KgaA
    • Teva Pharmaceutical Industries Ltd.
    • Others

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV2564

REPORT HIGHLIGHT

Biopharmaceutical and Biomedicine Market size was valued at USD 621,312 Million in 2023, expanding at a CAGR of 9.5% from 2024 to 2032.

The biopharmaceutical and biomedicine market encompasses the development, production, and commercialization of pharmaceuticals and medical products derived from biological sources. The growing adoption of precision medicine and personalized therapies, advancements in biotechnology such as gene editing and cell therapy, and increased focus on rare diseases and orphan drugs. However, restraints in the biopharmaceutical and biomedicine market include stringent regulatory requirements, high research and development costs, and challenges related to manufacturing and scaling up production. Opportunities abound in emerging markets, expansion into therapeutic areas with unmet medical needs, and strategic collaborations and partnerships for drug discovery and development.

Biopharmaceutical and Biomedicine Market- Market Dynamics

Surging rates of product launches and approvals in the biopharmaceuticals and biomedicines sector

The biopharmaceuticals and biomedicines sector is witnessing a notable surge in rates of product launches and approvals, indicative of the industry's rapid innovation and expansion. According to data from the U.S. Food and Drug Administration (FDA), there has been a steady increase in the number of biopharmaceutical products receiving regulatory approval in recent years, with a record number of new drug approvals reported annually. This trend underscores the industry's commitment to addressing unmet medical needs and improving patient outcomes through the development of groundbreaking biopharmaceutical and biomedicine products.

Biopharmaceutical and Biomedicine Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 9.5% over the forecast period (2024-2032)

Based on product type segmentation, Monoclonal Antibodies were predicted to show maximum market share in the year 2023

Based on application segmentation, Therapeutics was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Biopharmaceutical and Biomedicine Market- Segmentation Analysis:

The Global Biopharmaceutical and Biomedicine Market is segmented based on Product Type, Application, Therapeutic Area, and Region.

The market is divided into two categories based on product type: Monoclonal Antibodies widely used in therapeutic applications such as cancer treatment and autoimmune diseases. Nanomedicine is for diagnosing, treating, and preventing diseases at the molecular level, offering targeted delivery and enhanced efficacy in drug delivery and imaging applications.

The market is divided into three categories based on application: Utilized for treating diseases and medical conditions. Diagnostics are used for identifying and diagnosing diseases or conditions. Research and Development are applied in scientific research and experimental studies for drug discovery and development.

Biopharmaceutical and Biomedicine Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

North America and Europe stand as key players, boasting advanced healthcare infrastructure, robust research and development capabilities, and favorable regulatory environments. Meanwhile, the Asia-Pacific region demonstrates significant growth potential, driven by rising healthcare expenditures, increasing prevalence of chronic diseases, and expanding access to innovative therapies. Latin America and the Middle East & Africa regions also present opportunities for market expansion, albeit with challenges related to healthcare infrastructure, affordability, and regulatory complexities.

Biopharmaceutical and Biomedicine Market- Competitive Landscape:

Several key players vie for dominance through strategies such as research and development investments, mergers and acquisitions, and strategic partnerships. Companies including Roche, Pfizer, and Johnson & Johnson lead the market with diverse portfolios of biopharmaceutical products and extensive global reach. Additionally, innovative biotechnology firms such as Amgen, Biogen, and Gilead Sciences contribute to market competitiveness with groundbreaking therapies and novel drug candidates. As competition intensifies, companies focus on differentiation through product innovation, regulatory approvals, and market expansion efforts.

Recent Developments:

In May 2022, JSR Life Sciences unveiled a new business division called Similis Bio, aimed at collaborating with biopharmaceutical firms to enhance efficiency and lower costs associated with biosimilar development.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL BIOPHARMACEUTICAL AND BIOMEDICINE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Amgen Inc.

F. Hoffmann-La Roche Ltd

Johnson & Johnson Services, Inc.

Pfizer Inc.

Sanofi

Eli Lilly and Company

AbbVie Inc.

Novo Nordisk A/S

Bristol-Myers Squibb Company

NanoString

QIAGEN

Affimed GmbH

GSK plc.

Merck KgaA

Teva Pharmaceutical Industries Ltd.

Others

GLOBAL BIOPHARMACEUTICAL AND BIOMEDICINE MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Monoclonal Antibodies
  • Vaccines
  • Recombinant Human Insulin
  • Human Growth Hormone
  • Erythropoietin
  • Interferon
  • Others
  • Nanomedicine
  • Cell & Gene Therapy
  • Bioinformatics
  • Molecular Enzymes & Kits

GLOBAL BIOPHARMACEUTICAL AND BIOMEDICINE MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Therapeutics
  • Diagnostics
  • Research and Development

GLOBAL BIOPHARMACEUTICAL AND BIOMEDICINE MARKET, BY THERAPEUTIC AREA- MARKET ANALYSIS, 2019 - 2032

  • Oncology
  • Neurology
  • Cardiology
  • Immunology
  • Infectious Diseases
  • Rare Diseases

GLOBAL BIOPHARMACEUTICAL AND BIOMEDICINE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Biopharmaceutical and Biomedicine Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Biopharmaceutical and Biomedicine Market Snippet by Product Type
    • 2.1.2.Biopharmaceutical and Biomedicine Market Snippet by Application
    • 2.1.3.Biopharmaceutical and Biomedicine Market Snippet by Therapeutic Area
    • 2.1.4.Biopharmaceutical and Biomedicine Market Snippet by Country
    • 2.1.5.Biopharmaceutical and Biomedicine Market Snippet by Region
  • 2.2.Competitive Insights

3.Biopharmaceutical and Biomedicine Key Market Trends

  • 3.1.Biopharmaceutical and Biomedicine Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Biopharmaceutical and Biomedicine Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Biopharmaceutical and Biomedicine Market Opportunities
  • 3.4.Biopharmaceutical and Biomedicine Market Future Trends

4.Biopharmaceutical and Biomedicine Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Biopharmaceutical and Biomedicine Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Biopharmaceutical and Biomedicine Market Landscape

  • 6.1.Biopharmaceutical and Biomedicine Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Biopharmaceutical and Biomedicine Market - By Product Type

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2.Monoclonal Antibodies
      • 7.1.2.1.Vaccines
      • 7.1.2.2.Recombinant Human Insulin
      • 7.1.2.3.Human Growth Hormone
      • 7.1.2.4.Erythropoietin
      • 7.1.2.5.Interferon
      • 7.1.2.6.Others
    • 7.1.3.Nanomedicine
      • 7.1.3.1.Cell & Gene Therapy
      • 7.1.3.2.Bioinformatics
      • 7.1.3.3.Molecular Enzymes & Kits

8.Biopharmaceutical and Biomedicine Market - By Application

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2.Therapeutics
    • 8.1.3.Diagnostics
    • 8.1.4.Research and Development

9.Biopharmaceutical and Biomedicine Market - By Therapeutic Area

  • 9.1.Overview
    • 9.1.1.Segment Share Analysis, By Therapeutic Area, 2023 & 2032 (%)
    • 9.1.2.Oncology
    • 9.1.3.Neurology
    • 9.1.4.Cardiology
    • 9.1.5.Immunology
    • 9.1.6.Infectious Diseases
    • 9.1.7.Rare Diseases

10.Biopharmaceutical and Biomedicine Market- By Geography

  • 10.1.Introduction
    • 10.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2.North America
    • 10.2.1.Overview
    • 10.2.2.Biopharmaceutical and Biomedicine Key Manufacturers in North America
    • 10.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4.North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.2.5.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6.North America Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 10.2.7.U.S.
      • 10.2.7.1.Overview
      • 10.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3.U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5.U.S. Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 10.2.8.Canada
      • 10.2.8.1.Overview
      • 10.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3.Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5.Canada Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  • 10.3.Europe
    • 10.3.1.Overview
    • 10.3.2.Biopharmaceutical and Biomedicine Key Manufacturers in Europe
    • 10.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4.Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.5.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6.Europe Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 10.3.7.Germany
      • 10.3.7.1.Overview
      • 10.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3.Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5.Germany Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 10.3.8.Italy
      • 10.3.8.1.Overview
      • 10.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3.Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5.Italy Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 10.3.9.United Kingdom
      • 10.3.9.1.Overview
      • 10.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3.United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5.United Kingdom Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 10.3.10.France
      • 10.3.10.1.Overview
      • 10.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3.France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5.France Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 10.3.11.Russia
      • 10.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2.Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4.Russia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 10.3.12.Netherlands
      • 10.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2.Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4.Netherlands Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 10.3.13.Sweden
      • 10.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2.Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4.Sweden Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 10.3.14.Poland
      • 10.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2.Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4.Poland Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 10.3.15.Rest of Europe
      • 10.3.15.1.Overview
      • 10.3.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3.Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5.Rest of the Europe Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  • 10.4.Asia Pacific (APAC)
    • 10.4.1.Overview
    • 10.4.2.Biopharmaceutical and Biomedicine Key Manufacturers in Asia Pacific
    • 10.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4.Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.5.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6.Asia Pacific Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 10.4.7.India
      • 10.4.7.1.Overview
      • 10.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3.India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5.India Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 10.4.8.China
      • 10.4.8.1.Overview
      • 10.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3.China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5.China Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 10.4.9.Japan
      • 10.4.9.1.Overview
      • 10.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3.Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5.Japan Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 10.4.10.South Korea
      • 10.4.10.1.Overview
      • 10.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3.South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5.South Korea Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 10.4.11.Australia
      • 10.4.11.1.Overview
      • 10.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3.Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5.Australia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 10.4.12.Thailand
      • 10.4.12.1.Overview
      • 10.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3.Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5.Thailand Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 10.4.13.Indonesia
      • 10.4.13.1.Overview
      • 10.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3.Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5.Indonesia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 10.4.14.Philippines
      • 10.4.14.1.Overview
      • 10.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3.Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5.Philippines Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 10.4.15.Rest of APAC
      • 10.4.15.1.Overview
      • 10.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3.Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5.Rest of APAC Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  • 10.5.Latin America
    • 10.5.1.Overview
    • 10.5.2.Biopharmaceutical and Biomedicine Key Manufacturers in Latin America
    • 10.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4.Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.5.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6.Latin America Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 10.5.7.Brazil
      • 10.5.7.1.Overview
      • 10.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3.Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5.Brazil Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 10.5.8.Mexico
      • 10.5.8.1.Overview
      • 10.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3.Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5.Mexico Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 10.5.9.Argentina
      • 10.5.9.1.Overview
      • 10.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3.Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5.Argentina Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 10.5.10.Colombia
      • 10.5.10.1.Overview
      • 10.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3.Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5.Colombia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 10.5.11.Rest of LATAM
      • 10.5.11.1.Overview
      • 10.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3.Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5.Rest of LATAM Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  • 10.6.Middle East and Africa
    • 10.6.1.Overview
    • 10.6.2.Biopharmaceutical and Biomedicine Key Manufacturers in Middle East and Africa
    • 10.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4.Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.5.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6.Middle East and Africa Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 10.6.7.Saudi Arabia
      • 10.6.7.1.Overview
      • 10.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3.Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5.Saudi Arabia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 10.6.8.United Arab Emirates
      • 10.6.8.1.Overview
      • 10.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3.United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5.United Arab Emirates Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 10.6.9.Israel
      • 10.6.9.1.Overview
      • 10.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3.Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5.Israel Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 10.6.10.Turkey
      • 10.6.10.1.Overview
      • 10.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3.Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5.Turkey Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 10.6.11.Algeria
      • 10.6.11.1.Overview
      • 10.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3.Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5.Algeria Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 10.6.12.Egypt
      • 10.6.12.1.Overview
      • 10.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3.Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5.Egypt Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 10.6.13.Rest of MEA
      • 10.6.13.1.Overview
      • 10.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3.Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5.Rest of MEA Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)

11.Key Vendor Analysis- Biopharmaceutical and Biomedicine Industry

  • 11.1.Competitive Dashboard
  • 11.2.Company Profiles
    • 11.2.1.Amgen Inc.
    • 11.2.2.F. Hoffmann-La Roche Ltd
    • 11.2.3.Johnson & Johnson Services, Inc.
    • 11.2.4.Pfizer Inc.
    • 11.2.5.Sanofi
    • 11.2.6.Eli Lilly and Company
    • 11.2.7.AbbVie Inc.
    • 11.2.8.Novo Nordisk A/S
    • 11.2.9.Bristol-Myers Squibb Company
    • 11.2.10.NanoString
    • 11.2.11.QIAGEN
    • 11.2.12.Affimed GmbH
    • 11.2.13.GSK plc.
    • 11.2.14.Merck KgaA
    • 11.2.15.Teva Pharmaceutical Industries Ltd.
    • 11.2.16.Others

12.360 Degree Analyst View

13.Appendix

  • 13.1.Research Methodology
  • 13.2.References
  • 13.3.Abbreviations
  • 13.4.Disclaimer
  • 13.5.Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Biopharmaceutical and Biomedicine Market: Product Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Biopharmaceutical and Biomedicine Market, by Product Type 2019-2032 (USD Million)
  • TABLE Biopharmaceutical and Biomedicine Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Biopharmaceutical and Biomedicine Market, by Application 2019-2032 (USD Million)
  • TABLE Biopharmaceutical and Biomedicine Market: Therapeutic Area Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Therapeutic Area
  • TABLE Global Biopharmaceutical and Biomedicine Market, by Therapeutic Area 2019-2032 (USD Million)
  • TABLE Biopharmaceutical and Biomedicine Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Biopharmaceutical and Biomedicine Market, by Region 2019-2032 (USD Million)
  • TABLE North America Biopharmaceutical and Biomedicine Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Biopharmaceutical and Biomedicine Market, by Product Type, 2019-2032 (USD Million)
  • TABLE North America Biopharmaceutical and Biomedicine Market, by Application, 2019-2032 (USD Million)
  • TABLE North America Biopharmaceutical and Biomedicine Market, by Therapeutic Area, 2019-2032 (USD Million)
  • TABLE Europe Biopharmaceutical and Biomedicine Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Biopharmaceutical and Biomedicine Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Europe Biopharmaceutical and Biomedicine Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Biopharmaceutical and Biomedicine Market, by Therapeutic Area, 2019-2032 (USD Million)
  • TABLE Asia Pacific Biopharmaceutical and Biomedicine Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Biopharmaceutical and Biomedicine Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Biopharmaceutical and Biomedicine Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Biopharmaceutical and Biomedicine Market, by Therapeutic Area, 2019-2032 (USD Million)
  • TABLE Latin America Biopharmaceutical and Biomedicine Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Biopharmaceutical and Biomedicine Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Latin America Biopharmaceutical and Biomedicine Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Biopharmaceutical and Biomedicine Market, by Therapeutic Area, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Biopharmaceutical and Biomedicine Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Biopharmaceutical and Biomedicine Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Biopharmaceutical and Biomedicine Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Biopharmaceutical and Biomedicine Market, by Therapeutic Area, 2019-2032 (USD Million)